148 related articles for article (PubMed ID: 31899508)
1. LncRNA DLGAP1-AS2 modulates glioma development by up-regulating YAP1 expression.
Miao W; Li N; Gu B; Yi G; Su Z; Cheng H
J Biochem; 2020 Apr; 167(4):411-418. PubMed ID: 31899508
[TBL] [Abstract][Full Text] [Related]
2. LncRNA DLGAP1-AS2 regulates miR-503/cyclin D1 to promote cell proliferation in non-small cell lung cancer.
Wang L; Tang L; Ge T; Zhu F; Liu D; Guo H; Qian P; Xu N
BMC Pulm Med; 2021 Aug; 21(1):277. PubMed ID: 34454450
[TBL] [Abstract][Full Text] [Related]
3. DLGAP1-AS2 promotes estrogen receptor signalling and confers tamoxifen resistance in breast cancer.
Liang X; Zhao Y; Fang Z; Shao N; Zhai D; Zhang M; Yu L; Shi Y
Mol Biol Rep; 2022 May; 49(5):3939-3947. PubMed ID: 35449318
[TBL] [Abstract][Full Text] [Related]
4. Long Non-coding RNA DLGAP1-AS1 and DLGAP1-AS2: Two Novel Oncogenes in Multiple Cancers.
Zhao F; Tan F; Tang L; Du Z; Chen X; Yang Y; Zhou G; Yuan C
Curr Med Chem; 2023; 30(25):2822-2834. PubMed ID: 36121088
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA DLGAP1-AS1 promotes the progression of glioma by regulating the miR-1297/EZH2 axis.
Liu L; Li X; Shi Y; Chen H
Aging (Albany NY); 2021 Apr; 13(8):12129-12142. PubMed ID: 33901010
[TBL] [Abstract][Full Text] [Related]
6. LncRNA DLGAP1-AS2 overexpression associates with gastric tumorigenesis: a promising diagnostic and therapeutic target.
Soltani R; Amini M; Mazaheri Moghaddam M; Jebelli A; Ahmadiyan S; Bidar N; Baradaran B; MotieGhader H; Asadi M; Mokhtarzadeh A
Mol Biol Rep; 2022 Jul; 49(7):6817-6826. PubMed ID: 34981339
[TBL] [Abstract][Full Text] [Related]
7. The long noncoding RNA DLGAP1-AS2 facilitates cholangiocarcinoma progression via miR-505 and GALNT10.
Liu Z; Pan L; Yan X; Duan X
FEBS Open Bio; 2021 Feb; 11(2):413-422. PubMed ID: 33301605
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA kcna3 inhibits the progression of colorectal carcinoma through down-regulating YAP1 expression.
Zhong X; Lü M; Wan J; Zhou T; Qin B
Biomed Pharmacother; 2018 Nov; 107():382-389. PubMed ID: 30099342
[TBL] [Abstract][Full Text] [Related]
9. The knockdown of lncRNA DLGAP1-AS2 suppresses osteosarcoma progression by inhibiting aerobic glycolysis via the miR-451a/HK2 axis.
Zheng C; Li R; Zheng S; Fang H; Xu M; Zhong L
Cancer Sci; 2023 Dec; 114(12):4747-4762. PubMed ID: 37817462
[TBL] [Abstract][Full Text] [Related]
10. DLGAP1-AS2 promotes human colorectal cancer progression through trans-activation of Myc.
Ren C; Han H; Pan J; Chang Q; Wang W; Guo X; Bian J
Mamm Genome; 2022 Dec; 33(4):672-683. PubMed ID: 36222892
[TBL] [Abstract][Full Text] [Related]
11. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
He W; Zhang Y; Xia S
Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
[TBL] [Abstract][Full Text] [Related]
12. lncRNA CTBP1-AS2 promotes proliferation and migration of glioma by modulating miR-370-3p-Wnt7a-mediated epithelial-mesenchymal transition.
Li Y; Zong J; Zhao C
Biochem Cell Biol; 2020 Dec; 98(6):661-668. PubMed ID: 33150795
[TBL] [Abstract][Full Text] [Related]
13. METTL3-induced DLGAP1-AS2 promotes non-small cell lung cancer tumorigenesis through m
Zhang Q; Zhang Y; Chen H; Sun LN; Zhang B; Yue DS; Wang CL; Zhang ZF
Cell Cycle; 2022 Dec; 21(24):2602-2614. PubMed ID: 35972892
[TBL] [Abstract][Full Text] [Related]
14. Long non‑coding RNA LINC00473/miR‑195‑5p promotes glioma progression via YAP1‑TEAD1‑Hippo signaling.
Wang X; Li XD; Fu Z; Zhou Y; Huang X; Jiang X
Int J Oncol; 2020 Feb; 56(2):508-521. PubMed ID: 31894297
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA DLGAP1-AS2 facilitates Wnt1 transcription through physically interacting with Six3 and drives the malignancy of gastric cancer.
Lu J; Xu Y; Xie W; Tang Y; Zhang H; Wang B; Mao J; Rui T; Jiang P; Zhang W
Cell Death Discov; 2021 Sep; 7(1):255. PubMed ID: 34545072
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA DLGAP1-AS2 promotes tumorigenesis and metastasis by regulating the Trim21/ELOA/LHPP axis in colorectal cancer.
Wang X; Cheng H; Zhao J; Li J; Chen Y; Cui K; Tian L; Zhang J; Li C; Sun S; Feng Y; Yao S; Bian Z; Huang S; Fei B; Huang Z
Mol Cancer; 2022 Nov; 21(1):210. PubMed ID: 36376892
[TBL] [Abstract][Full Text] [Related]
17. LncRNA NFIA-AS2 promotes glioma progression through modulating the miR-655-3p/ZFX axis.
Xin J; Zhao YH; Zhang XY; Tian LQ
Hum Cell; 2020 Oct; 33(4):1273-1280. PubMed ID: 32779154
[TBL] [Abstract][Full Text] [Related]
18. YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo.
Sun D; Li X; He Y; Li W; Wang Y; Wang H; Jiang S; Xin Y
Oncotarget; 2016 Dec; 7(49):81062-81076. PubMed ID: 27835600
[TBL] [Abstract][Full Text] [Related]
19. LncRNA LINC00899 promotes progression of acute myeloid leukaemia by modulating miR-744-3p/YY1 signalling.
Dong X; Xu X; Guan Y
Cell Biochem Funct; 2020 Oct; 38(7):955-964. PubMed ID: 32157707
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA PICSAR knockdown inhibits the progression of cutaneous squamous cell carcinoma by regulating miR-125b/YAP1 axis.
Lu X; Gan Q; Gan C; Zheng Y; Cai B; Li X; Li D; Yin G
Life Sci; 2021 Jun; 274():118303. PubMed ID: 32841663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]